Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Low-dose oral minoxidil improved hair growth in most pediatric patients with mild side effects.

The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Low-energy fractional CO2 laser therapy significantly improves hair regrowth in women with female-pattern hair loss.

The supplement significantly improves hair density and appearance in people with hair loss.

Low-dose oral minoxidil is safe for treating children's hair disorders.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Bicalutamide may reduce unwanted hair growth caused by minoxidil in women with hair loss.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.

Bicalutamide is more effective and safer than spironolactone for treating female hair loss.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

DHT stops hair regrowth in mice, similar to human hair loss.

Finasteride may improve prostate cancer treatment outcomes.